Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Nature Reviews. Clinical Oncology|March 6, 2025
Enhancing immunotherapy with tumour-responsive nanomaterialsStephen W Linderman, Louis DeRidder, Lucía Sanjurjo, et al.
Molecular Cancer|November 18, 2025
Bispecific antibodies and nanotechnology: a strategic alliance in cancer immunotherapyElisa Battistini, Philipp Lapuhs, Alberto Jiménez, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 17, 2024
Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumorsAna M López-Estévez, Lucía Sanjurjo, Ángela Turrero, et al.
Theranostics|January 3, 2017
Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicineMarta Monguió-Tortajada, Santiago Roura, Carolina Gálvez-Montón, et al.
Journal of Clinical Medicine|June 6, 2020
The Circulating Fatty Acid Transporter Soluble CD36 Is Not Associated with Carotid Atherosclerosis in Subjects with Type 1 and Type 2 Diabetes MellitusEsmeralda Castelblanco, Lucía Sanjurjo, Maria Barranco-Altirriba, et al.
Ebiomedicine|May 12, 2019
CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell contentCristina Bárcena, Gemma Aran, Luís Perea, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 22, 2018
CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78)Gemma Aran, Lucía Sanjurjo, Cristina Bárcena, et al.
Journal of Leukocyte Biology|December 4, 2013
Human scavenger protein AIM increases foam cell formation and CD36-mediated oxLDL uptakeNúria Amézaga, Lucía Sanjurjo, Josep Julve, et al.
Communications Biology|December 21, 2021
Chemokines modulate glycan binding and the immunoregulatory activity of galectinsLucía Sanjurjo, Iris A Schulkens, Pauline Touarin, et al.
Cell Reports|February 2, 2017
The Nuclear Receptor LXR Limits Bacterial Infection of Host Macrophages through a Mechanism that Impacts Cellular NAD MetabolismJonathan Matalonga, Estibaliz Glaria, Mariana Bresque, et al.
Pageof 3